A phase 2 trial of flavopiridol (Alvocidib) and cisplatin in platin-resistant ovarian and primary peritoneal carcinoma: MC0261. [electronic resource]
Producer: 20130206Description: 55-62 p. digitalISSN:- 1095-6859
- Adolescent
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Cell Survival -- drug effects
- Cisplatin -- administration & dosage
- Cohort Studies
- Disease-Free Survival
- Drug Resistance, Neoplasm
- Female
- Flavonoids -- administration & dosage
- Humans
- Middle Aged
- Ovarian Neoplasms -- drug therapy
- Peritoneal Neoplasms -- drug therapy
- Piperidines -- administration & dosage
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.